IP Library Granted Patent US 10,184,122
Granted Patent B2
US 10,184,122 · App. 14/805,341 · Granted Jan 22, 2019

Transposon end compositions and methods for modifying nucleic acids

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,184,122
App. No.
14/805,341
Granted
Jan 22, 2019
Kind
B2
Abstract

The present invention provides methods, compositions and kits for using a transposase and a transposon end for generating extensive fragmentation and 5′-tagging of double-stranded target DNA in vitro, then using a DNA polymerase for generating 5′- and 3′-tagged single-stranded DNA fragments without performing a PCR amplification reaction, wherein the first tag on the 5′-ends exhibits the sequence of the transferred transposon end and optionally, an additional arbitrary sequence, and the second tag on the 3′-ends exhibits a different sequence from the sequence exhibited by the first tag. The method is useful for generating 5′- and 3′-tagged DNA fragments for use in a variety of processes, including processes for metagenomic analysis of DNA in environmental samples, copy number variation (CNV) analysis of DNA, and comparative genomic sequencing (CGS), including massively parallel DNA sequencing (so-called “next generation sequencing).

Claims (25)

1. A method for preparing a library of nucleic acid fragments representative of a target nucleic acid comprising:

(a) contacting a target nucleic acid with a plurality of transposomes, wherein the target nucleic acid is double-stranded DNA, and the transposomes comprise a transposase and a pair of transposon end polynucleotides;

(b) incubating the target nucleic acid and transposomes under conditions whereby the target nucleic acid is fragmented into a plurality of nucleic acid fragments comprising one of the transposon end polynucleotides attached to an end of the nucleic acid fragments; and

(c) non-selectively amplifying the nucleic acid fragments, thereby obtaining a library of nucleic acid fragments that is representative of the target nucleic acid from which the fragments were generated.

2. The method of claim 1 , wherein the target nucleic acid comprises genomic DNA.

3. The method of claim 1 , wherein the target nucleic acid comprises cDNA.

4. The method of claim 1 , wherein the transposon end polynucleotides comprise a tag domain selected from the group consisting of a sequencing tag domain, a capture tag domain, and an amplification tag domain.

5. The method of claim 1 , wherein the transposase is selected from a Tn5 transposase, a hyperactive Tn5 transposase, and a Mu transposase.

6. The method of claim 1 , wherein (b) comprises extending the 3′ ends of the nucleic acid fragments.

7. The method of claim 6 , wherein (b) comprises contacting the nucleic acid fragments with a strand-displacing nucleic acid polymerase.

8. The method of claim 6 , wherein (b) comprises contacting the nucleic acid fragments with a nucleic acid polymerase having 5′-to-3′ exonuclease activity.

9. The method of claim 6 , wherein (b) comprises contacting the nucleic acid fragments with a ligase and a nucleic acid polymerase lacking both strand-displacing and 5′-to-3′ exonuclease activities.

10. The method of claim 6 , wherein (b) comprises contacting the nucleic acid fragments with a ligase and a ligation oligonucleotide.

11. The method of claim 1 , wherein the non-selectively amplifying is selected from the group consisting of a strand-displacement amplification reaction, a rolling circle amplification reaction, a loop-mediated amplification reaction, and PCR.

12. The method of claim 1 , wherein (c) comprises capturing the amplified nucleic acid fragments on a surface.

13. The method of claim 12 , wherein the surface comprises at least a million attached nucleic acid fragments.

14. The method of claim 12 , wherein the surface is on a substrate selected from the group consisting of a bead, a chip, a slide, a microtiter plate, a tube, a microchannel, and a dipstick.

15. The method of claim 12 , wherein the surface comprises at least a million captured nucleic acid fragments.

16. The method of claim 1 , further comprising sequencing the library of amplified nucleic acid fragments.

17. A method for preparing a library of nucleic acid fragments comprising:

(a) contacting a target nucleic acid with a plurality of transposomes, wherein the target nucleic acid is double-stranded DNA, and the transposomes comprise a transposase and a pair of transposon end polynucleotides;

(b) incubating the target nucleic acid and transposomes under conditions whereby the target nucleic acid is fragmented into a plurality of nucleic acid fragments comprising one of the transposon end polynucleotides attached to at least one end of the nucleic acid fragments; and

(c) non-selectively amplifying the nucleic acid fragments, thereby obtaining a library of nucleic acid fragments.

18. The method of claim 17 , wherein the library of nucleic acid fragments is representative of nucleic acid sequences of the plurality of nucleic acid fragments comprising one of the transposon end polynucleotides attached to each end of the nucleic acid fragments.

19. The method of claim 17 , wherein the library of nucleic acid fragments lacks nucleic acid sequences of the plurality of nucleic acid fragments comprising one of the transposon end polynucleotides attached to a single end of the nucleic acid fragments.

Assignments (3)
MERGER Recorded Dec 3, 2020
From: EPICENTRE TECHNOLOGIES CORPORATION
To: ILLUMINA, INC.
Reel/Frame 054585/0512 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2019
From: JENDRISAK, JEROME; DAHL, GARY; GRUNENWALD, HAIYING LI; CARUCCIO, NICHOLAS
To: EPICENTRE TECHNOLOGIES CORPORATION
Reel/Frame 047918/0217 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 21, 2015
From: JENDRISAK, JEROME; DAHL, GARY; GRUNENWALD, HAIYING LI; CARUCCIO, NICHOLAS
To: EPICENTRE TECHNOLOGIES CORPORATION
Reel/Frame 036844/0134 →
Cited By (19)
US 12,252,734 US 12,252,735 US 12,252,736 US 12,252,737 US 12,305,219 US 12,305,220 US 12,305,221 US 12,319,925 US 12,359,193 US 12,365,892 US 12,371,687 US 12,371,743 US 12,469,162 US 12,505,571 US 12,540,320 US 12,571,038 US 12,606,819 US 12,606,859 US 12,630,874